MiniMed™ 780G System

Worry less about exact carb counting


People with type 1 diabetes find more mealtime freedom with the MiniMed™ 780G system.


Get started

Simplera Sync™ sensor now FDA-approved!


We're ramping up manufacturing to support customers globally and will begin a limited launch in the U.S. in the fall of 2025. We'll share more details soon.

Get on the MiniMed™ 780G system with Guardian™ 4 sensor today to enjoy all the benefits of automation and Meal Detection™ technology.
MiniMed™ 780G system with SmartGuard™ technology
Smart devices sold separately

You deserve to enjoy your food.


The only system with Meal Detection™ technology that automatically delivers correction doses every 5 minutes — allowing for miscalculated carbs or occasionally missed boluses.

So dig in, and enjoy every bite with less stress!


#1 insulin pump in overall satisfaction1-3

Get started on the MiniMed 780G system


New to Medtronic Current Medtronic customer

Features of the MiniMed 780G system

Meal Detection™ technology icon

Meal Detection™ technology

If your carb counts are underestimated or if you occasionally miss a meal dose, the system automatically delivers a correction dose.§

Auto correction icon

Auto corrections

Help prevent hyper- and hypoglycemia with automatic insulin adjustments all day and night.Ω

Compatible with the Medtronic Extended™ infusion set icon

Compatible with the Medtronic Extended™ infusion set

The first and only infusion set that can be worn for up to 7 days.

Treat to target icon

Treat to target

Flexible glucose targets as low as 100 mg/dL.††

Ready for more mealtime freedom? Get started on the MiniMed 780G system


A member of our team will reach out to you for additional information. If you have questions, please contact us at 888-882-8602 (M-F 9 a.m. - 6 p.m. CT).




How can we communicate with you?


MiniMed 780G system components

Insulin pump

Insulin pump

Based on info received from the CGM every 5 minutes, the pump makes automatic adjustments and corrections to your insulin delivery.

Left arrow Right arrow
Continuous Glucose Monitor (CGM)

Continuous glucose monitor (CGM)

The Guardian 4 sensor measures sugar levels every 5 minutes, sending levels to the pump. There are also no fingersticks with SmartGuard technology.Ω

Left arrow Right arrow
Infusion set

Infusion set

Allows for continuous and discreet delivery of insulin through a thin, flexible tube and can be worn up to 7 days.

Left arrow Right arrow
Smartphone app

Smartphone app

Get notified of highs and lows with the MiniMed Mobile app. Care partners can download the CareLink Connect app to stay in the know.

Left arrow Right arrow
Apple® Watch integration

Apple® WatchΦ

Get alerts for highs or lows directly to your Apple® Watch with the MiniMed Mobile app.

Left arrow Right arrow
780G features background image

Real people. Real experiences.


Our advanced diabetes technology ensures you have the confidence to navigate your own unique journey.
Chris #MedtronicChampion since 2008

“It works great at keeping my blood sugar in range and back to goal.” — Chris

Thoughts and opinion are his own. Individual results may vary.
Mike #MedtronicChampion since 2008

“If I forget to bolus, I know the MiniMed™ 780G system has me covered.” — Mike

Compensated for his time. Thoughts and opinion are his own. Individual results may vary.
Jasmine #MedtronicChampion since 2008

“My pump has my back! I don't have to be perfect with my carb counting.” — Jasmine

Compensated for her time. Thoughts and opinion are her own. Individual results may vary.
Geoffrey
#MedtronicChampion
since 2023

More information and resources for the MiniMed 780G system


Upgrade your system icon

Upgrade your system

For customers currently on a Medtronic insulin pump, sign in to Diabetes.shop to see your options.
Training modules icon

Training modules

Access our online learning portal to complete your MiniMed™ 780G system training.
Product support icon

Product support

Discover answers to your technical questions.
User guides and manuals icon

User guides and manuals

Find the complete set of guides and quick references for your MiniMed™ 780G system.
My account icon

My account

Sign in to your Diabetes.shop account.

Footnotes
Refers to SmartGuard™ feature. Individual results may vary.
Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
§ Due to inherent real-world study limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences.
 Refers to SmartGuard™ feature. Individual results may vary.
†† Glucose targets should be chosen following a consultation with your healthcare provider.
‡‡ Fingersticks required in manual mode and to enter SmartGuard™. If symptoms don’t match alerts and readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard™.
Φ Smart devices sold separately. For a list of compatible devices, visit http://bit.ly/CheckDevices.

References
1. Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed.
2. Individual results may vary.
3. dQ&A US Diabetes Patient Panel Report; Customer Overall Satisfaction, n=146; Q4 2023: P.52 (November 2023).


Important safety information: MiniMed 780G system with SmartGuard technology with Simplera Sync sensor

The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G System includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Simplera Sync™ sensor can be used one time and has a life up to 6 days, followed by a grace period of 24 hours. During the grace period, the sensor will continue to work as it did during the first 6 days, to allow the patient to change their sensor more flexibly. However, some sensors may not survive the full wear period for a variety of reasons. Please be prepared to replace the sensor during the grace period to ensure sensor glucose values continue to be monitored.

The Simplera Sync™ sensor is not intended to be used directly to make therapy adjustments while the MiniMed 780G is operating in manual mode. All therapy adjustments in Manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Simplera Sync™ sensor. The Simplera Sync™ sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Simplera Sync™ sensor in the abdomen or other body sites, including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

The Medtronic MiniMed™ 780G System consists of the following devices: MiniMed™ 780G Insulin Pump, Simplera Sync™ sensor, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide Test Strips. The system requires a prescription from a healthcare professional.

WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.

WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g-simplera-sync and the appropriate user guide at https://www.medtronicdiabetes.com/download-library.


Important safety information: MiniMed 780G system with SmartGuard technology with Guardian 4 sensor

The MiniMed 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed 780G system consists of the following devices: MiniMed 780G insulin pump, the Guardian 4 transmitter, the Guardian 4 sensor, One-press serter, the Accu-Chek Guide Link blood glucose meter, and the Accu-Chek Guide test strips. The system requires a prescription from a healthcare professional.

The Guardian 4 sensor is intended for use with the MiniMed 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian 4 sensor is indicated for up to seven days of continuous use.

The Guardian 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian 4 sensor. The Guardian 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

WARNING: Do not use the SmartGuard feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard feature.

WARNING: Do not use the MiniMed 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library